Prospective validation of the prognostic 31‐gene expression profiling test in primary cutaneous melanoma

Abstract

Gene expression profiling Class 2 result and SNB positivity were independently associated with recurrence and distant metastasis in primary CM patients. GEP testing may have additive prognostic utility in initial staging work-up of these patients.